Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Shirl Dipasquale
Observed name:
S. Di Pasquale
Institutions:
Johns Hopkins University,
Johns Hopkins Medicine
Observed institutions:
Johns Hopkins University,
Johns Hopkins Medicine,
Johns Hopkins Hospital,
Sidney Kimmel Comprehensive Cancer Center
OpenAlex ID:
A5057622500
Outcomes of Observation vs Stereotactic Ablative Radiation for Oligometastatic Prostate Cancer
2020
·
Ryan Phillips
, William Yue Shi
, et al.
·
JAMA Oncology
·
1,166
PDF
The Role of Stereotactic Body Radiation Therapy for Pancreatic Cancer: A Single-Institution Experience
2015
·
Shalini Moningi
, Avani S. Dholakia
, et al.
·
Annals of Surgical Oncology
·
163
Phase II Randomized Study of Salvage Radiation Therapy Plus Enzalutamide or Placebo for High-Risk Prostate-Specific Antigen Recurrent Prostate Cancer After Radical Prostatectomy: The SALV-ENZA Trial
2022
·
Phuoc T. Tran
, Kathryn Lowe
, et al.
·
Journal of Clinical Oncology
·
43
A phase II randomized trial of RAdium-223 dichloride and SABR Versus SABR for oligomEtastatic prostate caNcerS (RAVENS)
2020
·
Hamza Hasan
, Matthew P. Deek
, et al.
·
BMC Cancer
·
30
PDF
Outcomes of Radium-223 and Stereotactic Ablative Radiotherapy Versus Stereotactic Ablative Radiotherapy for Oligometastatic Prostate Cancers: The RAVENS Phase II Randomized Trial
2025
·
Jarey H. Wang
, Alexander D. Sherry
, et al.
·
Journal of Clinical Oncology
·
29
PDF
Prostate-Specific Membrane Antigen PET Response Associates with Metastasis-Free Survival After Stereotactic Ablative Radiation in Oligometastatic Prostate Cancer
2024
·
Philip Sutera
, Matthew P. Deek
, et al.
·
Advances in Radiation Oncology
·
7
PDF
Stereotactic Ablative Radiation and Short-Term Androgen Ablation for Intermediate-Risk Localized Prostate Adenocarcinoma: Safety and Toxicity From a Prospective Single-Arm Phase II Trial (NCT01517451)
2019
·
R. Phillips
, H. Hasan
, et al.
·
International Journal of Radiation Oncology*Biology*Physics
Lesion Response to Stereotactic Body Radiation Therapy Concurrent With Nelfinavir for Solid Tumor Oligometastases
2017
·
J. Yan
, P.T. Tran
, et al.
·
International Journal of Radiation Oncology*Biology*Physics
PDF
Single-Arm Phase 2 Study of Stereotactic Body Radiation Therapy (SBRT) Concurrent with Nelfinavir for Solid Tumor Oligometastases
2017
·
S.A. Terezakis
, J. Herman
, et al.
·
International Journal of Radiation Oncology*Biology*Physics
PDF
Show more works
View as search
Works count:
9
Citation count:
1,437
H-index:
6
I10-index:
5
Year
Topic
Type